COVID-19:  Screening, updates and safety protocols: 

How to Apply

The Joint Research Ethics Board (JREB) adopts a proportionate approach to ethics review such that the level of JREB review is determined by the level of risk presented by the research. Thus, there are two levels of JREB review possible for brand new studies: Full Board review and Delegated review (expedited). For example, clinical trials fall under Full Board review, whereas minimal risk studies fall under Delegated review.

For Full Board review, the submission deadline is 3 weeks prior to the monthly JREB meeting. Please see the 'Submission Deadlines and Meeting Dates' tab. Submissions for Delegated review can be sent in at all times. However, at the discretion of the JREB Chair, the study may be assigned to Full Board review.

Electronic copies should be sent to @email.

Please click on the following link to access the JREB Submission Process Flow Chart: 


Was this page helpful?

If you would like us to follow-up with you to provide assistance, please enter your preferences for how you wish to be contacted below: